<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <contributors>
    <authors>
      <author>Reina-Ortiz, C.</author>
      <author>Constantinides, M.</author>
      <author>Fayd-Herbe-de-Maudave, A.</author>
      <author>Présumey, J.</author>
      <author>Hernandez, J.</author>
      <author>Cartron, G.</author>
      <author>Giraldos, D.</author>
      <author>Díez, R.</author>
      <author>Izquierdo, I.</author>
      <author>Azaceta, G.</author>
      <author>Palomera, L.</author>
      <author>Marzo, I.</author>
      <author>Naval, J.</author>
      <author>Anel, A.</author>
      <author>Villalba, M.</author>
    </authors>
  </contributors>
  <titles>
    <title>Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients</title>
    <secondary-title>Oncoimmunology</secondary-title>
  </titles>
  <doi>10.1080/2162402X.2020.1853314</doi>
  <pages/>
  <volume/>
  <number/>
  <dates>
    <year>2021</year>
    <pub-dates>
      <date>2021</date>
    </pub-dates>
  </dates>
  <abstract/>
</record>

</records>
</xml>